Posted on

cbd oil dementia

Cbd oil dementia

CBD can be administered in different forms, but the most common is as oil, which can be dropped onto the tongue , contained in gel capsule s, or applied to the skin directly. However, it is also available in pill forms or as an inhalant.

Let’s start with the basics of CBD. It comes from the hemp plant , which is related to the marijuana plant . The plant is dried and the resin is extracted. This compound contains 2 parts: tetrahydrocannabinol (THC) and cannabidiol (CBD).

What Are the Benefits of CBD for Seniors with Dementia?

Because of how dementia affects the brain, a senior may become agitated or anxious in everyday situations. Sometimes this agitation can even turn vio lent. But remember that these behavior changes are caused by the disease and are not your loved one’s fault. CBD may be able to help alleviate these symptoms .

What Is CBD?

As dementia progresses, brain tissue actually dies and function is lost for good. This process can take the time or it can happen very rapidly. In some trials, CBD showed promising results to help stop or even reverse the loss of brain function and memory loss in dementia patients. Additionally, CBD may help stimulate the brain to help keep connections within the brain and help seniors potentially delay the effects of dementia.

Studies have reported changes in the endocannabinoid system in the brain of patients with Alzheimer’s disease (AD), playing a role in the pathophysiology of AD. Cannabinoids have been shown to have neuroprotective properties, reduce neuroinflammation, and enhance neurogenesis. Evidence suggests that the utilization of marijuana products containing both tetrahydrocannabinol (THC) and cannabidiol (CBD) or CBD alone have been effective and safe for use in older people with agitation associated with dementia. A review in 2017 summarized positive findings for therapeutic benefits of cannabinoids in agitation of AD and dementia, but there was no definitive conclusion because of varying cannabinoid products. Cannabinoids were shown to be well tolerated, with few short-term side effects. This differs from first-line medications utilized for dementia behaviors, which can have unwanted side effects. Further research regarding the safety, efficacy, and variability of these products in older people is needed.